Latest filing intelligence

Merck & Co., Inc. (MRK)

Read the latest MRK filing as a structured brief: high-signal changes, financial snapshot, and direct links back to the official SEC source.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

Merck & Co., Inc. latest filing summary

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for MRK shows revenue was $65.0B and net income was $18.3B.

Key changes

What stands out in the latest report

  • Revenue moved to $65.0B from $64.2B (+1.3% vs prior).
  • Net income moved to $18.3B from $17.1B (+6.6% vs prior).
  • Diluted EPS moved to $7.28 from $6.74 (+8.0% vs prior).

Current read

Mixed read

Financial snapshot

Latest reported figures

Revenue $65.0B
Net income $18.3B
EPS $7.28
Operating cash flow $16.5B

Trend section

Recent revenue trend

Q3 $16.7B

Period ended 2024-09-30

Q1 $15.5B

Period ended 2025-03-31

Q2 $15.8B

Period ended 2025-06-30

Q3 $17.3B

Period ended 2025-09-30

Trend section

Recent EPS trend

Q3 N/A

Filed period trend snapshot.

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking